Updated: Sun, 10/06/2024 - 10:30

From Saturday, Oct. 5 through Monday, Oct. 7, the Downtown and Macdonald Campuses will be open only to McGill students, employees and essential visitors. Many classes will be held online. Remote work required where possible. See Campus Public Safety website for details.


Du samedi 5 octobre au lundi 7 octobre, le campus du centre-ville et le campus Macdonald ne seront accessibles qu’aux étudiants et aux membres du personnel de l’Université McGill, ainsi qu’aux visiteurs essentiels. De nombreux cours auront lieu en ligne. Le personnel devra travailler à distance, si possible. Voir le site Web de la Direction de la protection et de la prévention pour plus de détails.

We’ve moved

The Rosalind and Morris Goodman Cancer Institute can now be found at www.goodmancancer.ca

Visit the new site

 

Donors make a Difference: Rong Ma on Unveiling the Epigenetic Secrets of Melanoma

Rong Ma, a third-year Ph.D. student in the McGill-Kyoto International Joint Ph.D. program, has been recognized with the 2023-2024 Donner Studentship Award. Under the co-supervision of Dr. Ian Watson and Dr. Guillaume Bourque, Rong's research delves into the intricacies of melanoma, with a particular focus on epigenetic dysregulation and its implications for tumor progression and treatment response.

Melanoma, a form of skin cancer notorious for its aggressive nature, has long been studied from a genetic standpoint. Rong’s research sheds light on the often-overlooked realm of epigenetics, exploring how modifications to gene expression patterns can drive melanoma development, metastasis, and resistance to immunotherapy. By employing cutting-edge multi-omic techniques and sophisticated bioinformatic analyses, Rong aims to deepen our understanding of melanoma biology and pave the way for more effective therapeutic interventions with a particular focus on enhancing the efficacy of immunotherapies.

Receiving the Donner Studentship Award is a significant asset to Rong’s research. This scholarship provides crucial financial support, enabling Rong to access state-of-the-art epigenomic profiling techniques and essential computational resources. Furthermore, by removing financial constraints this support will allow Rong to gather extensive information, ensuring inclusive exploration of the biological questions posed in this research.

Beyond the tangible benefits, the recognition has bolstered Rong’s confidence in his work and reaffirmed his commitment to a career in cancer research. Whether in academia or industry, he aims to continue his pursuit of groundbreaking research that impacts the lives of those affected by cancer. This award is also meaningful for Rong outside of the lab: “Moreover, this recognition has inspired me to actively engage in fundraising initiatives and advocate for cancer research, as these efforts are vital for sustaining progress in the field and raising public awareness about its significance,” he shared.

Rong's journey has not been without its challenges. Like most students, he has encountered setbacks and rejections along the way particularly in the process of securing research funding. However, he has realized that these rejections do not diminish the importance of his research and reflects “Rather than fixating on the outcome of the applications, it’s important to appreciate the beauty of the research process itself." With unwavering support from his mentors and peers, Rong has turned these obstacles into opportunities for growth.

As Rong continues his quest to unravel the epigenetic secrets of melanoma, his story serves as a testament to the power of perseverance, passion, and community support in driving scientific progress. “It is a great honor to have been selected as the recipient of the prestigious 2023 Donner Foundation Studentship. I would like to express my utmost gratitude to the foundation and GCI community for providing me with this unique opportunity and tremendous support,” he shared. With the Donner Studentship Award propelling him forward, Rong stands poised to make significant contributions to our understanding of cancer biology and the development of more effective treatments for patients worldwide.

Back to top